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ABSTRACT
The present study establishes whether the pH of samples is crucial for measuring total carnitine in human plasma by 
tandem mass spectrometry and if it is necessary to neutralize the samples after alkaline hydrolysis of acylcarnitines. 
Free and total carnitine of ten plasma samples were measured by a radioenzymatic assay as a reference method, 
and forward there were analyzed by tandem mass spectrometry divided into two groups: treated with hydrochloric 
acid and without hydrochloric acid measuring each sample five times for both variables. Free and total carnitine 
concentrations were similar for the radioenzymatic essay and tandem mass spectrometry. There was no significant 
difference between the two analyzed variables (treated with hydrochloric acid and without hydrochloric acid). It 
could be concluded that the pH of samples is no crucial for measuring total carnitine in plasma by tandem mass 
spectrometry, and it is not necessary to neutralize the samples after alkaline hydrolysis of acylcarnitines, then the 
shorter method, without adding hydrochloric acid can be used for total carnitine measurement in plasma by tandem 
mass spectrometry.
Keywords: carnitine; tandem mass spectrometry; radioenzymatic assay.
1. Universidad de Caldas - Universidad de Manizales, Manizales. Colombia. Correo: jose.osorio_o@ucaldas.edu.co -  http://orcid.org/0000-0002-6875-3215
2. Universidad de Caldas, Manizales. Colombia. Correo: jorge.castaneda_s@ucaldas.edu.co - http://orcid.org/0000-0002-3632-5216
Influence of using hydrochloric acid for measuring the concentration of total carnitine
256 Duazary: Revista Internacional de Ciencias de la Salud / ISSN: 1794-5992 / Vol. 15, No. 3, septiembre - diciembre de 2018
DOI: http://dx.doi.org/10.21676/2389783X.2416
RESUMEN
El presente estudio establece, si el pH al cual se procesan las muestras, condiciona la determinación de la carnitina 
total en plasma, mediante el uso de espectrometría de masas en tándem; así mismo analiza, si es necesario neutralizar 
las muestras luego de la hidrólisis alcalina de las acilcarnitinas. Carnitina libre y total de 10 muestras de plasma fueron 
medidas mediante el ensayo radioenzimático, como método de referencia. Posteriormente fueron medidas cinco 
veces cada muestra, mediante espectrometría de masas en tándem utilizando ácido hidroclorhídrico y sin usar ácido 
hidroclorhídrico. Las concentraciones de carnitina libre y total, fueron similares utilizando ensayo radioenzimático y 
espectrometría de masas en tándem. No se encontró diferencias significativas entre las dos variables analizadas (con 
ácido hidroclorhídrico, o sin ácido hidroclórhídrico). Puede concluirse que el pH de las muestras no es crucial para 
medir carnitina total en plasma por espectrometría de masas en tandem y no es necesario neutralizar las muestras 
luego de la hidrólisis alcalina de las acilcarnitinas. El método más corto puede ser utilizado para tal fin.
Palabras clave: carnitine; espectrometría de masas en tandem; ensayo radioenzimático.
INTRODUCTION 
The study of inherited inborn errors is a big field that needs a basic technology for its 
diagnosis1 The alterations of fatty acid mito-
chondrial β-oxidation an important part of the 
inherited inborn errors have as the main guide, 
the measurements of concentrations of free 
carnitine, total carnitine, and acylcarnitines in 
different tissues and fluids2. All of the currently 
identified mitochondrial fatty acid β-oxidation 
defects are autosomal recessive. The clini-
cal manifestations result from the inability of 
FA-oxidizing tissues to keep up with increased 
energy demands; therefore, target organs of FA 
oxidation defects include skeletal and cardiac 
muscles in addition to the liver3. Hypoketotic 
hypoglycemia is present in nearly all the defects, 
and usually occurs following an intercurrent ill-
ness but may occasionally be seen after a short 
fast. These diseases have been associated with 
sudden infant death syndrome, cyclic vomiting 
syndrome, Reye syndrome, and maternal com-
plications of pregnancy3. Tandem mass spec-
trometry provides an easy way to measure acyl-
carnitines4, and new developments have been 
designed for the study of free and total carnitine 
in blood5 and plasma6 by tandem mass spec-
trometry. A quaternary ammonium functional 
group is distinctive for carnitine and acylcarni-
tines, which enable them to form positive ions 
(cations) that are polar and non-volatile7. Ions 
produced in the source are selected by MS1 for 
transmission to the collision cell (figure 1). The 
fragments generated after collision-induced dis-
sociation (CID) are transmitted to MS2 where 
they are again selected for transmission to the 
detector. Ions transmitted by MS1 to the colli-
sion cell are called precursor ions (commonly 
referred as “parent” ions), and the fragments 
produced from CID are product ions (known as 
“daughter” ions). During the derivatization pro-
cess, butyl esters of acylcarnitines are formed. 
These butyl esters are well suited for analysis 
by MS/MS since they already carry a positive 
charge and accordingly no additives are needed 
in the mobile phase.  Both butyl esters deriva-
tives and underivatized carnitine and acylcar-
nitines share a common product ion upon CID, 
which is singly charged with a mass of 85 Da, 
corresponding to +CH2-CH=CH-COOH. This 
fragment results from the loss of elements of 
both (CH3)3N and C4H8 and the side chain 
acyl group as RCOOH. Selective analysis of 
only those molecules that produce and 85 Da 
product ion is accomplished using Pre ion scan 
mode. For acylcarnitine profiles, precursor ion 
scans of the peak at m/z 85 are monitored in the 
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range m/z 250-500. As such, they are detected 
as their respective molecular ions8. The pre-
cursor ion spectra thereby obtained shows the 
molecular ion species corresponding to the 
butylated carnitine and acylcarnitines in the 
sample9 and therefore provides information 
about the characteristic profile for the majority 
of mitochondrial fatty acid oxidation disorders, 
and some organic acidurias.  For the analysis of 
L-carnitine by MS/MS it is possible to obtain a 
characteristic fragment of 103 Da derived  from 
the loss of both the trimethylamine group and 
the elements of C4H8, and both the unlabelled 
and labelled forms of carnitine as butyl esters 
exhibit prominent molecular cations at m/z 218 
and 221 respectively10.  
Figure 1. Tandem mass spectrometer11
                         (Q1 or MS1)                (Q2)                   (Q3 or MS3)
The machine is divided in five parts: the ion 
source where the ionization takes place; the 
first mass analyzer (Q1 or MS1) for component 
ion selection; the quad (quadrupole) collision 
chamber (Q2) where ion fragmentation by CID 
is performed; the second mass analyzer (Q3 or 
MS2) for fragment ion selection; and the particle 
multiplier for ion detection.
In spite of for many laboratories around the 
world radioenzymatic assay is still a useful 
method for free and total carnitine measure-
ment12,13, tandem mass spectrometry constitutes 
the more precise technique for this kind of sizes; 
however, when total carnitine is measured by 
tandem mass spectrometry, total carnitine is 
measured after alkaline hydrolysis of acylcar-
nitines14. Plasma samples are neutralized by the 
addition of hydrochloric acid and then buffered 
before the analysis by tandem mass spectrom-
etry, but these steps spend more chemicals and 
are time-consuming15. The present work ana-
lyzes this situation searching to save time and 
chemicals used during this process.
MATERIALS AND METHODS
The present study is experimental. Random 
blood samples from 10 adult volunteers were 
collected by venipuncture and centrifuged 
(2300g x 5min) to separate the plasma. All the 
samples were stored at -80°C until they were 
assayed. Before the analysis, all the samples were 
centrifuged (13000g x 2min). All the chemicals 
used were of analytical grade. Deuterated car-
nitine ([d3]Cn) was obtained from Cambridge 
isotopes laboratories (Andover, MA, USA).  
Radioenzymatic assay (REA) for the 
quantitative determination of plasma free and 
total L-carnitine16
The assay is based on the reaction catalyzed by 
carnitine acetyltransferase (CAT) (EC number 
2.3.1.7) as follows:  
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      L-Carnitine + [1-14C] acetyl-CoA -----------
-> [1-14C] acylcarnitine + CoASH
This method measures the production of radio-
labelled15. For the total carnitine measurement, 
the plasma needed to be hydrolyzed: 100µl of 
plasma was mixed with 100µl of 1M KOH, cen-
trifuged (3500g. x 1min) and incubated at 45°C 
in shaking water-bath for 60min. 100µl of 1M 
HCl was added and vortexed. 100µl of 0.8M 
HEPES hemi-Na salt (pH 7,80) was added, the 
solution was vortexed and centrifuged (10000g 
x 1min), being ready for the analysis. 
Assay procedure 
All samples and control plasma (pool of stored 
plasma samples), as well as standard (L-carnitine 
0.1 mM were analyzed in triplicate. 50µl of 
plasma or 100µl of hydrolyzed plasma or 50µl 
of carnitine standards were placed in polysty-
rene (75 X 11.5mm) tube and made up to 200µl 
with nanopure water.  Pre-mixed reaction mix 
was added (750µl) (Reaction mix: Buffer solu-
tion 400µl (240mM HEPES, 4mM EDTA, pH 
7.3); H2O 288µl; Tetrathionate 50µl (sodium 
tetrathionate 10mg/ml in nanopure water pre-
pared on the day of the assay); Acetyl-CoA 10 
µ (Acetyl-CoA  (Li salt) 25mM (final concentra-
tion 25µM)); [1-14C] Acetyl-CoA 2µl ([1 -14C] 
Acetyl-CoA about 14500 dpm/ml assay), and the 
tubes were kept on ice for at least 15min as the 
temperature of the contents of the tubes should 
be below 10°C before adding the CAT. The reac-
tion was started by adding 50 µl of the CAT 
solution (30U/ml) to all samples, while on ice 
(total reaction volume 1.0 ml).  The tubes were 
capped and centrifuged at 4°C (2579g x 1min). 
All of the tubes were transferred into the shak-
ing water bath at 30°C and incubated for 30min. 
Then the tubes were placed on ice for 5min, and 
exactly 0.5 ml of a continuously stirred slurry of 
AG1-X8 resin (chloride form) was added. The 
samples were vortexed and placed on ice for 
30min with occasional mixing. After centrifug-
ing (3500g x1min, 4°C), 800µl of the superna-
tant was put into a scintillation vial, and 5ml of 
scintillation fluid was added. The counting pro-
gram for 14C was used.  
Calculations 
A calibration curve from the standard (L-carnitine 
0.1 mM) (dpm - blank) of 20, 40, 60, 80 and 100 
µmol/l carnitine was drawn. The dpm minus 
blank of each sample was plotted on the calibra-
tion curve, and the corresponding carnitine con-
centration was determined. For total carnitine, 2 
multiplied the value. Acylcarnitine = Total – Free. 
Samples were analyzed using a Packard Liquid 
Scintillation Counter (model: Tri-carb 2100 TR).
Plasma sample analysis by tandem mass 
spectrometry 
Card preparation for free and total carnitine 
measurement by tandem mass spectrometry. 
Osorio and Pourfarzam developed the method 
used, in 200217. A standard internal volume 
of 20µl (300µM [d3] Cn in 50% (v/v) metha-
nol: water) was added to 180µl of plasma, and 
the solution was mixed before being left to 
stand for 15min. Aliquots of 20µl from this 
plasma were spotted on filter paper card, and 
the cards were put in the fume-cupboard for 
60min to dry. These cards were used for the 
measurement of free carnitine concentrations. 
For total carnitine determination 16µl of 1m 
KOH was added to 100µl of the above internal 
standard-plasma mixture. After mixing and 
centrifugation (3000g x 1min) samples were 
incubated at 45oc in a shaking water-bath for 
60min to hydrolyze the acylcarnitines. 16µl 4n 
hydrochloric acid was then added to the first 
group of samples before mixing and centri-
fuging again. The procedure was repeated for 
the second group of samples but without the 
addition of hydrochloric acid. Samples were 
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spotted on filter paper cards and dried at room 
temperature. Spots were punched from the 
card (6.35mm diameter, corresponding to 12µl 
of plasma) into microtiter plates and 500µl of 
pure methanol was added to each sample. The 
plates were placed on an orbital shaker for 
30min and sonicated for 15min for extraction 
of acylcarnitines. The plates were returned 
to the shaker for a further 2 hours and soni-
cated again for another 30min. The discs were 
removed, and the resulting eluate was evapo-
rated under air at 45 0C until dry and re-dis-
solved in 100µl of 70% (v/v) acetonitrile in 
water before to analysis by ESI -MS/MS. The 
study was performed with a scan range of 150-
170 (m/z). The ratio value for carnitine/internal 
standard intensities was obtained and multi-
plied by 30µM after smoothing the peaks twice 
(peak width 0.80 Da- Savitzky Golay method), 
centering (min peak width at the half height 
two channels, centroid top 90%) without back-
ground subtraction. All the analyses were per-
formed using a Quattro II, triple quadrupole 
mass spectrometer (Micromass, Manchester, 
UK) equipped with an ion source (ESI) and a 
micro mass MassLynx data system. The sam-
ples were injected into the mass spectrometer 
using a Jasco AS980 autosampler and a Jasco 
PU980 HPLC pump (Jasco International Co., 
Tokyo, Japan). 
Statistical analysis 
To determine the relationship between the two 
used methods a regression analysis was per-
formed by using the Least squares method (y = 
a + bx), to find regression lines of best fit, and 
a correlation coefficient was calculated. The stu-
dent’s t-test was used to look for a statistical dif-
ference between the two analyzed variables. 
Declaration on ethical aspects 
Written consent was obtained from 10 adult vol-
unteers from who the samples were collected. 
RESULTS 
Free and total carnitine concentrations were sim-
ilar for radioenzymatic assay and tandem mass 
spectrometry (Y=0,96X+0,45 and Y=0,95X-0,69 
respectively). There are no significant differ-
ences (P>0.05 in all comparisons) between the 
two analyzed variables (treated with hydrochlo-
ric acid and without hydrochloric acid). Table 
1 shows the values for free and total carnitine 
measured by radioenzymatic assay compared 
to values for free carnitine using tandem mass 
spectrometry, as well as the values obtained for 
the two groups of samples treated with and with-
out hydrochloric acid for total carnitine mea-
surement by tandem mass spectrometry.
DISCUSSION 
Radioenzymatic assay18,19 is regarded as the 
standard gold method for carnitine measure-
ment. This procedure determines free carnitine 
by enzymatically converting it to radioactively 
labeled acetylcarnitine. Total carnitine is mea-
sured after alkaline hydrolysis of acylcarnitines. 
The acylcarnitine concentration is thus calculated 
as the difference between total and free carnitine 
values. The use of tandem mass spectrometry to 
measure carnitine in dried plasma spots is advan-
tageous by permitting to confirm systemic carni-
tine deficiency after obtaining the acylcarnitine 
profile, and also later on to monitor the response 
to treatment. Carnitine contains a quaternary 
ammonium functional group, making them posi-
tive ions (cations) that are polar and non-volatile. 
The underivatized carnitine shows a common 
product ion, which is singly charged with a mass 
of 103 Da. This singly charged mass allows the 
use of ESI-MS/MS for the analysis of these com-
pound20. However, the methods used for measur-
ing carnitine can be influenced by several factors 
when samples are obtained or even during the 
laboratory procedure when samples are analyzed. 
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When this study was commenced, an improved 
method for the analysis of acylcarnitine esters 
by ESI-MS/MS had been established in the lab-
oratory. Different factors including the type of 
solvent for acylcarnitine extraction, extraction 
conditions, the effect of derivatization, type of 
derivatization, derivatization conditions (con-
centration of acid, temperature, time), mobile 
phase composition and MS/MS condition had 
been investigated, and optimum conditions had 
been established. Recent studies have shown that 
the temperature used during the procedure can 
affect the carnitine/acylcarnitine ratio21,22. The 
conservation of samples also can influence the 
metabolite measurements. It is accepted that the 
correct quantification of free carnitine and acyl-
carnitines in plasma relies on rapid centrifugation 
of the blood after collection or storage on ice and 
centrifugation within one h. Before to analysis, 
the resulting plasma samples are kept at −20°C or 
−80°C for short- and long-term storage, respec-
tively. Scientific literature includes the analysis of 
some factors which are determinants in carnitine 
measurement as it has been reported for differ-
ent acetonitrile concentrations during tandem 
mass spectrometry analysis, peaked significantly 
increased at an acetonitrile concentration of 90% 
and above23,24 or for the presence or not of an inter-
nal standard25,26 or the anticoagulant used during 
sampling27. However, there is no any report in the 
scientific literature related to using or not HCl 
for plasma sample preparation. According to the 
results of the present work, it can be concluded 
that the pH of samples is no crucial for measuring 
total carnitine in plasma by tandem mass spec-
trometry, and it is not necessary to neutralize the 
samples after alkaline hydrolysis of acylcarnitines, 
then the shorter method, without adding hydro-
chloric acid can be used for total carnitine mea-
surement in plasma by tandem mass spectrom-
etry, saving time and materials which enables this 
method as more economic and easy to perform.  
Table 1. Concentration of free and total carnitine in plasma samples, using two methods
Sample No. Freecarnitine
Free
carnitine
Total 
carnitine
Total 
carnitine
MS/MS
Total carnitine
MS/MS
REA
μmol/L
(SD± 0,5)
MS/MS μmol/L
(SD± 0,3)
REA
μmol/l
(SD± 0,4)
With HCl
μmol/l
(SD± 0,4)
Without HCl
μmol/l
(SD± 0,3)
1 44.8 45.2 55.1 55.3 54.9
2 33.0 32.3 41.0 40.1 40.5
3 38.5 39.0 52.1 52.0 52.5
4 48.0 47.8 52.4 53.1 53.3
5 36.0 35.8 47.9 48.5 48.9
6 35.5 35.9 43.0 42.8 42.1
7 29.9 29.3 39.9 40.0 40.8
8 37.5 38.0 48.5 49.1 49.0
9 32.0 31.2 46.0 45.6 44.2
10 47.1 48.1 68.1 67.3 65.8
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